Edition:
United Kingdom

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

4.44USD
8:59pm GMT
Change (% chg)

$0.06 (+1.37%)
Prev Close
$4.38
Open
$4.36
Day's High
$4.45
Day's Low
$4.32
Volume
632
Avg. Vol
13,686
52-wk High
$9.32
52-wk Low
$1.96

Select another date:

Tue, Jan 16 2018

BRIEF-Biomerica Q2 Loss Per Share $0.03

* BIOMERICA ANNOUNCES SECOND QUARTER FINANCIAL RESULTS; SALES UP 12.7% FOR THE QUARTER

BUZZ-Biomerica: China's FDA approves colorectal screening test for cancer

** Diagnostic test maker's shares up as much as 64.77 pct to touch record high of $7.25 - biggest intraday pct gain since May 2016

BRIEF-China FDA Approves Biomerica Colorectal Screening Test To Help Identify The Early Warning Signs Of Colorectal Cancer

* CHINA FOOD AND DRUG ADMINISTRATION (CFDA) APPROVES BIOMERICA COLORECTAL SCREENING TEST TO HELP IDENTIFY THE EARLY WARNING SIGNS OF COLORECTAL CANCER Source text for Eikon: Further company coverage:

BRIEF-Biomerica Enters Into At Market Issuance Sales Agreement With B. Riley FBR

* BIOMERICA INC - ‍ON DEC. 1, 2017, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC - SEC FILING​

BRIEF-Biomerica extends license agreement with Celtis Pharm

* Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

BRIEF-Biomerica Inc Q1 ‍net sales $1.4 million

* Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​

BRIEF-Biomerica commences clinical studies for new Gastroenterology H. Pylori test

* Biomerica commences clinical studies for new Gastroenterology H. Pylori test

Select another date: